Structural and functional characterization of two alpha-synuclein strains
- PMID: 24108358
- PMCID: PMC3826637
- DOI: 10.1038/ncomms3575
Structural and functional characterization of two alpha-synuclein strains
Abstract
α-Synuclein aggregation is implicated in a variety of diseases including Parkinson's disease, dementia with Lewy bodies, pure autonomic failure and multiple system atrophy. The association of protein aggregates made of a single protein with a variety of clinical phenotypes has been explained for prion diseases by the existence of different strains that propagate through the infection pathway. Here we structurally and functionally characterize two polymorphs of α-synuclein. We present evidence that the two forms indeed fulfil the molecular criteria to be identified as two strains of α-synuclein. Specifically, we show that the two strains have different structures, levels of toxicity, and in vitro and in vivo seeding and propagation properties. Such strain differences may account for differences in disease progression in different individuals/cell types and/or types of synucleinopathies.
Figures
Similar articles
-
Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy.Nature. 2020 Feb;578(7794):273-277. doi: 10.1038/s41586-020-1984-7. Epub 2020 Feb 5. Nature. 2020. PMID: 32025029 Free PMC article.
-
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.Nature. 2011 Aug 14;477(7362):107-10. doi: 10.1038/nature10324. Nature. 2011. PMID: 21841800 Free PMC article.
-
Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein.J Mol Biol. 2008 Oct 31;383(1):214-23. doi: 10.1016/j.jmb.2008.08.039. Epub 2008 Aug 23. J Mol Biol. 2008. PMID: 18775438 Free PMC article.
-
α-Synuclein Conformational Strains as Drivers of Phenotypic Heterogeneity in Neurodegenerative Diseases.J Mol Biol. 2023 Jun 15;435(12):168011. doi: 10.1016/j.jmb.2023.168011. Epub 2023 Feb 13. J Mol Biol. 2023. PMID: 36792008 Review.
-
Neuropathology and molecular diagnosis of Synucleinopathies.Mol Neurodegener. 2021 Dec 18;16(1):83. doi: 10.1186/s13024-021-00501-z. Mol Neurodegener. 2021. PMID: 34922583 Free PMC article. Review.
Cited by
-
Effects of Mutations and Post-Translational Modifications on α-Synuclein In Vitro Aggregation.J Mol Biol. 2022 Dec 15;434(23):167859. doi: 10.1016/j.jmb.2022.167859. Epub 2022 Oct 19. J Mol Biol. 2022. PMID: 36270580 Free PMC article. Review.
-
Two-color coincidence single-molecule pulldown for the specific detection of disease-associated protein aggregates.Sci Adv. 2023 Nov 17;9(46):eadi7359. doi: 10.1126/sciadv.adi7359. Epub 2023 Nov 15. Sci Adv. 2023. PMID: 37967183 Free PMC article.
-
Polyphosphates induce amyloid fibril formation of α-synuclein in concentration-dependent distinct manners.J Biol Chem. 2021 Jan-Jun;296:100510. doi: 10.1016/j.jbc.2021.100510. Epub 2021 Mar 4. J Biol Chem. 2021. PMID: 33676889 Free PMC article.
-
Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril.Sci Rep. 2016 Aug 4;6:30891. doi: 10.1038/srep30891. Sci Rep. 2016. PMID: 27488222 Free PMC article.
-
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons.Front Cell Dev Biol. 2020 Sep 4;8:559791. doi: 10.3389/fcell.2020.559791. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33015057 Free PMC article. Review.
References
-
- Ross C. A. & Poirier M. A. Protein aggregation and neurodegenerative disease. Nat. Med. 10 Suppl, S10-7 (2004). - PubMed
-
- Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2, 492–501 (2001). - PubMed
-
- Lee H. J., Choi C. & Lee S. J. Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J. Biol. Chem. 277, 671–678 (2002). - PubMed
-
- Jensen P. H., Nielsen M. S., Jakes R., Dotti C. G. & Goedert M. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson’s disease mutation. J. Biol. Chem. 273, 26292–26294 (1998). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources